Venture-backed companies mature enough to sell shares to the public haven’t been rushing the door. Only 10 companies have floated shares since the start of May. But those that have enjoy pretty good results.
You are browsing the archive for Supernus Pharmaceuticals - peHUB.
Supernus Pharmaceuticals Inc., a Rockville, Md.-based developer of CNS products, has raised around $35 million in its second non-dilutive financing round. Last April, it had announced a $75 million transaction secured by royalties generated from partnered products using Supernus technologies. The company in 2006 raised $45 million in venture capital from firms like Abingworth Management, New Enterprise Associates and OrbiMed Advisors.